Search research articles
Contact Us
Filters
Showing results (1-10 of 97) with videos related to
Page
of 10
Sort By:
Alimentary Pharmacology & Therapeutics
|
July 30, 2025
Editorial: Evolving Trends in Ulcerative Colitis Management-Insights From the Lothian Cohort
Shintaro Akiyama
Intestinal Research
|
November 14, 2025
Optimizing Janus kinase inhibitor therapy for ulcerative colitis: a real-world perspective
Shintaro Akiyama
Alimentary Pharmacology & Therapeutics
|
January 23, 2025
Letter: Toward Intra-Class Switching With JAK Inhibitors? Authors' Reply
Shintaro Akiyama, Toshimitsu Fujii
Alimentary Pharmacology & Therapeutics
|
January 9, 2025
Editorial: Individualising JAK Inhibitor Selection for Patients With Ulcerative Colitis-Authors' Reply
Shintaro Akiyama, Toshimitsu Fujii
Journal of Gastroenterology
|
April 25, 2026
Reply to "Letter to "Increasing age at diagnosis raises malignancy risk and aminosalicylate intolerance influences therapeutic strategies in ulcerative colitis""
Shintaro Akiyama, Kiichiro Tsuchiya
Journal of Translational Autoimmunity
|
June 28, 2021
Distinct roles of interleukin-17 and T helper 17 cells among autoimmune diseases
Shintaro Akiyama, Atsushi Sakuraba
Alimentary Pharmacology & Therapeutics
|
July 31, 2025
Letter: Efficacy Versus Effectiveness-An Important Nuance Among Real-World Studies: Authors' Reply
Shintaro Akiyama, Toshimitsu Fujii
Journal of Medical Virology
|
September 19, 2020
Safety of nontumor necrosis factor-targeted biologics in the COVID-19 pandemic
Shintaro Akiyama, Akihiro Yamada, Atsushi Sakuraba
The New England Journal of Medicine
|
June 1, 2012
Colorectal-cancer screening
Shintaro Akiyama, Koichi Suyama, Toshimi Takano
Intestinal Research
|
March 13, 2024
The evolving understanding of histology as an endpoint in ulcerative colitis
Shintaro Akiyama, Yusuke Miyatani, David T Rubin
Page
of 10
Search research articles
Search
Showing results (1-10 of 97) with videos related to
Sort By:
Page
of 10
Alimentary Pharmacology & Therapeutics
|
July 30, 2025
Editorial: Evolving Trends in Ulcerative Colitis Management-Insights From the Lothian Cohort
Shintaro Akiyama
Intestinal Research
|
November 14, 2025
Optimizing Janus kinase inhibitor therapy for ulcerative colitis: a real-world perspective
Shintaro Akiyama
Alimentary Pharmacology & Therapeutics
|
January 23, 2025
Letter: Toward Intra-Class Switching With JAK Inhibitors? Authors' Reply
Shintaro Akiyama, Toshimitsu Fujii
Alimentary Pharmacology & Therapeutics
|
January 9, 2025
Editorial: Individualising JAK Inhibitor Selection for Patients With Ulcerative Colitis-Authors' Reply
Shintaro Akiyama, Toshimitsu Fujii
Journal of Gastroenterology
|
April 25, 2026
Reply to "Letter to "Increasing age at diagnosis raises malignancy risk and aminosalicylate intolerance influences therapeutic strategies in ulcerative colitis""
Shintaro Akiyama, Kiichiro Tsuchiya
Journal of Translational Autoimmunity
|
June 28, 2021
Distinct roles of interleukin-17 and T helper 17 cells among autoimmune diseases
Shintaro Akiyama, Atsushi Sakuraba
Alimentary Pharmacology & Therapeutics
|
July 31, 2025
Letter: Efficacy Versus Effectiveness-An Important Nuance Among Real-World Studies: Authors' Reply
Shintaro Akiyama, Toshimitsu Fujii
Journal of Medical Virology
|
September 19, 2020
Safety of nontumor necrosis factor-targeted biologics in the COVID-19 pandemic
Shintaro Akiyama, Akihiro Yamada, Atsushi Sakuraba
The New England Journal of Medicine
|
June 1, 2012
Colorectal-cancer screening
Shintaro Akiyama, Koichi Suyama, Toshimi Takano
Intestinal Research
|
March 13, 2024
The evolving understanding of histology as an endpoint in ulcerative colitis
Shintaro Akiyama, Yusuke Miyatani, David T Rubin
Page
of 10